Loading market dashboard
NovaBridge Biosciences
NBPHealthcareNASDAQUS
Loading analysis workspace
Estimates, scoring, valuation assumptions, and peer comparison in one research surface.
NovaBridge Biosciences · Forecast overview
Bars show expected revenue while the line tracks expected EPS.
| Period | Revenue avg | Revenue range | EBITDA | EPS avg | Analysts |
|---|---|---|---|---|---|
| Dec 2030 | $436.14M | $436.14M - $436.14M | $87.23M | -$5.403 | 1 |
| Dec 2029 | $167.81M | $167.81M - $167.81M | $33.56M | -$5.884 | 1 |
| Dec 2028 | $106.56M | $106.56M - $106.56M | $21.31M | -$5.368 | 2 |
| Dec 2027 | $0.00 | $0.00 - $0.00 | $0.00 | -$5.024 | 0 |
| Dec 2026 | $0.00 | $0.00 - $0.00 | $0.00 | -$3.338 | 0 |
| Dec 2025 | $0.00 | $0.00 - $0.00 | $0.00 | -$0.769 | 0 |
| Dec 2024 | $0.00 | $0.00 - $0.00 | $0.00 | -$1.265 | 0 |
| Dec 2023 | $26.27M | $26.27M - $26.27M | $573.2K | -$11.532 | 1 |